Correlation Between US Lithium and Aequus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both US Lithium and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Lithium and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between US Lithium Corp and Aequus Pharmaceuticals, you can compare the effects of market volatilities on US Lithium and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Lithium with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Lithium and Aequus Pharmaceuticals.

Diversification Opportunities for US Lithium and Aequus Pharmaceuticals

0.24

Correlation Coefficient

US Lithium  Aequus Pharmaceuticals

Modest diversification

The 3 months correlation between LITH and Aequus is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding US Lithium Corp and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and US Lithium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Lithium Corp are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of US Lithium i.e., US Lithium and Aequus Pharmaceuticals go up and down completely randomly.

Pair Corralation between US Lithium and Aequus Pharmaceuticals

Given the investment horizon of 90 days US Lithium Corp is expected to generate 0.94 times more return on investment than Aequus Pharmaceuticals. However, US Lithium Corp is 1.06 times less risky than Aequus Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest  0.04  in US Lithium Corp on September 20, 2024 and sell it today you would lose (0.03) from holding US Lithium Corp or give up 75.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

US Lithium Corp  vs.  Aequus Pharmaceuticals

US Lithium Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days US Lithium Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Aequus Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with US Lithium and Aequus Pharmaceuticals

The main advantage of trading using opposite US Lithium and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Lithium position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.

The idea behind US Lithium Corp and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.